Symbol | Marktkapitalisierung | Preis | Veränderung % | Volumen | Relatives Volumen | KGV | EPS-Verd. TTM | EPS-Verd. Wachstum TTM YoY | Dividendenrendite % TTM | Sektor | Analystenrating |
---|---|---|---|---|---|---|---|---|---|---|---|
VISTNVISTIN PHARMA ASA | 1,1 B NOK | 25,0 NOK | +0,40% | 22,18 K | 1,89 | 18,05 | 1,39 NOK | +37,91% | 2,01% | Gesundheitstechnologie | — |
NYKDNYKODE THERAPEUTICS ASA | 898 M NOK | 2,770 NOK | +0,73% | 1,89 M | 0,30 | — | −1,27 NOK | +22,29% | 0,00% | Gesundheitstechnologie | Kauf |
BGBIOBERGENBIO ASA | 313,24 M NOK | 10,368 NOK | +29,37% | 1,9 M | 4,17 | — | −4,91 NOK | +85,91% | 0,00% | Gesundheitstechnologie | Kauf |
LYTIXLYTIX BIOPHARMA AS | 296,67 M NOK | 6,40 NOK | +7,02% | 225,78 K | 7,32 | — | −1,85 NOK | — | 0,00% | Gesundheitstechnologie | — |
ULTIULTIMOVACS ASA | 75,67 M NOK | 2,270 NOK | +3,18% | 621,27 K | 1,73 | — | −4,34 NOK | +26,84% | 0,00% | Gesundheitstechnologie | Verkaufen |
AABSARCTIC BIOSCIENCE AS | 54,29 M NOK | 2,08 NOK | −2,80% | 50,29 K | 0,73 | — | −1,91 NOK | −27,80% | 0,00% | Gesundheitstechnologie | Neutral |